Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS AND VIEWS

Parkinson’s disease grafts benefit from well-timed growth factor

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Nature 582, 39-40 (2020)

doi: https://doi.org/10.1038/d41586-020-01486-3

References

  1. 1.

    Barker, R. A., Drouin-Ouellet, J. & Parmar, M. Nature Rev. Neurol. 11, 492–503 (2015).

    PubMed  Article  Google Scholar 

  2. 2.

    Barker, R. A., Parmar, M., Studer, L. & Takahashi, J. Cell Stem Cell 21, 569–573 (2017).

    PubMed  Article  Google Scholar 

  3. 3.

    Tabar, V. & Studer, L. Nature Rev. Genet. 15, 82–92 (2014).

    PubMed  Article  Google Scholar 

  4. 4.

    Gantner, C. W. et al. Cell Stem Cell 26, 511–526 (2020).

    PubMed  Article  Google Scholar 

  5. 5.

    Kirik, D., Cederfjäll, E., Halliday, G. & Petersén, A. Neurobiol. Dis. 97, 179–188 (2017).

    PubMed  Article  Google Scholar 

  6. 6.

    Rosenblad, C., Martinez-Serrano, A. & Björklund, A. Neuroscience 75, 979–985 (1996).

    PubMed  Article  Google Scholar 

  7. 7.

    Kikuchi, T. et al. Nature 548, 592–596 (2017).

    PubMed  Article  Google Scholar 

  8. 8.

    Deuse, T. et al. Nature Biotechnol. 37, 252–258 (2019).

    PubMed  Article  Google Scholar 

  9. 9.

    Gornalusse, G. G. et al. Nature Biotechnol. 35, 765–772 (2017).

    PubMed  Article  Google Scholar 

  10. 10.

    Luk, K. C. et al. Science 338, 949–953 (2012).

    PubMed  Article  Google Scholar 

  11. 11.

    Steinbeck, J. A. & Studer, L. Neuron 86, 187–206 (2015).

    PubMed  Article  Google Scholar 

Download references

Competing Interests

L.S. is a scientific founder and paid consultant of BlueRock Therapeutics and an inventor on patents related to the differentiation of dopamine neurons from pluripotent stem cells. V.T. is a founding investigator and paid consultant of BlueRock Therapeutics.

Subjects

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links